Fluzoparib
Fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR) -deficient cells.
Product Specifications
CAS Number
1358715-18-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
472.4
Molecular Formula
C22H16F4N6O2
Notes
Research use only, not for human use.
Receptor
PARP
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
